Funding for this research was provided by:
National Institute of Allergy and Infectious Diseases (ZIA AI001086-08)
U.S. Public Health Service (P30-AG010133)
Japan Society for the Promotion of Science (fellowship)
Creutzfeldt–Jakob Disease Foundation (none)
Massachusetts Alzheimer's Disease Research Center (P50 AG005134)
Received: 18 December 2019
Accepted: 26 January 2020
First Online: 22 February 2020
Ethics approval and consent to participate
: All brain samples were collected post-mortem obtained from sources indicated in Online Resource Table InternalRef removed and Acknowledgements in [CitationRef removed] and de-identified prior to RT-QuIC testing.
: Not applicable given that the brain samples were collected post-mortem and de-identified.
: MAM, ES, AK and BC are named as inventors on patent applications pertaining to the tau RT-QuIC methodologies.